[Percutaneous transfemoral arterial implantation of drug delivery system for arterial infusion therapy of advanced primary hepatic carcinoma].
To study the efficiency of arterial infusion chemotherapy via drug delivery system (DDS) for advanced primary hepatic carcinoma. Hepatic arterial infusion chemotherapy was performed in 82 cases of primary hepatic carcinoma with no indication for operation or transarterial embolism treatment. The patients were divided into 2 group as follows: (1) Group A: 42 patients were treated intra-arterially once every 1 or 2 weeks via implanted DDS. (2) Group B: 40 patients were treated through one bolus arterial infusion chemotherapy, once every month. The response rate (CR + PR) was 38.1% and 15.0% respectively in group A and B (P < 0.05); the 0.5-, 1- and 2- year survival rate was 61.9%, 28.6% and 9.5% respectively in group A, but 20%, 5%, 0% respectively in group B (P < 0.01); Liver, biliary, gastrointestinal and bone marrow toxicity in group A patients was greatly lower than those in group B patients. Intermittent arterial infusion chemotherapy via DDS significantly improves survival and quality of life in patients with advanced primary hepatic carcinoma.